Genzyme's consent decree is finalised
This article was originally published in Scrip
Executive Summary
The US FDA and Genzyme have finalised the consent decree regarding the company's manufacturing plant in Allston, Massachusetts. As expected, the company will have to hand over $175 million in unlawful profits from products made at the plant (scripnews.com, 22 April 2010).